Author

Paul P. Eijk

Amsterdam University Medical Centers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Bauke YlstraiD· 2 shared Anna LavrovaiD· 1 shared Bart A. WestermaniD· 1 shared C. Mircea S. TesileanuiD· 1 shared Chaimaa Bakali· 1 shared Enrico FranceschiiD· 1 shared Erik van DijkiD· 1 shared Iris J. de HeeriD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Bauke YlstraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

W. R. Vallentgoed, Youri Hoogstrate, Karin A. van Garderen, Levi van Hijfte, Erik van Dijk, Mathilde C.M. Kouwenhoven, Johanna M. Niers, Kaspar Draaisma, Ivonne Martin, Wendy W.J. de Leng, C. Mircea S. Tesileanu, Iris J. de Heer, Maud Diepeveen, Anna Lavrova, Paul P. Eijk, , Pim J. French

The paper analyzes multi-omics data from IDH-mutant astrocytomas to identify molecular markers of malignant progression linked to cell cycling and DNA methylation changes.

Nature Cancer · Aug 19, 2025Peer-reviewedCancer Biology

Engineering large chromosomal deletions by CRISPR-Cas9

Thomas F. Eleveld, Chaimaa Bakali, Paul P. Eijk, Phylicia Stathi, Lianne E. M. Vriend, Pino J. Poddighe, Bauke Ylstra

This paper describes a CRISPR-Cas9 method to engineer arm-level chromosomal deletions in neuroblastoma cell lines to study their oncogenic role.

Nucleic Acids Research · Jun 14, 2021Peer-reviewedGenetics